£108.92

It has never been this cheap. We have no record of a lower price.

£109 today · cheaper than every other day in the last 3 months

Springer Mitochondria: Anti-cancer Target Third Millennium - Springer

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 46 days · 46 data points (no recent data)

Historical
Generating forecast…
£109.14 £108.90 £108.95 £109.00 £109.06 £109.11 £109.16 28 July 2026 08 August 2026 19 August 2026 30 August 2026 11 September 2026
View at Amazon ↗

Price data last checked 45 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 46 days • 1 price levels

Days at Price
46 days 0 12 23 35 46 £109 Days at Price

Price Analysis

Most common price: £109 (46 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 46 days

Description

This comprehensive medical text examines mitochondria as promising therapeutic targets for cancer treatment, combining fundamental research with clinical applications. Written by leading specialists, the book explores how mitochondrial dysfunction drives oncological pathologies whilst also documenting mitochondrial roles in non-neoplastic diseases such as Friedreich's ataxia. The work bridges basic science and practical clinical relevance, offering healthcare practitioners and researchers an in-depth understanding of mitochondrial biology in disease prevention and treatment strategies for the modern era.

Key Features

Springer-published academic text focusing on mitochondria as viable anti-cancer drug targets for oncology research and clinical practice.

Combines chapters on fundamental mitochondrial research with clinically relevant applications written by recognised field specialists.

Explores mitochondrial involvement in both neoplastic cancers and non-neoplastic diseases including Friedreich's ataxia.

Designed for internal medicine practitioners, healthcare professionals and researchers seeking comprehensive understanding of mitochondrial pathology.

Product Specifications

Barcode

No barcode data available